Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

INmune Bio Inc (0Y2.BE)

Compare
6.30
+0.30
+(5.00%)
As of 1:08:04 PM GMT+2. Market Open.
Loading Chart for 0Y2.BE
  • Previous Close 6.00
  • Open 5.95
  • Bid 5.70 x --
  • Ask 6.90 x --
  • Day's Range 5.85 - 6.30
  • 52 Week Range 4.20 - 11.00
  • Volume 0
  • Avg. Volume 4
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 7, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 0Y2.BE

View More

Performance Overview: 0Y2.BE

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

0Y2.BE
37.55%
S&P 500 (^GSPC)
10.43%

1-Year Return

0Y2.BE
41.67%
S&P 500 (^GSPC)
1.33%

3-Year Return

0Y2.BE
11.89%
S&P 500 (^GSPC)
19.39%

5-Year Return

0Y2.BE
39.42%
S&P 500 (^GSPC)
88.83%

Compare To: 0Y2.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0Y2.BE

View More

Valuation Measures

As of 4/10/2025
  • Market Cap

    140.41M

  • Enterprise Value

    121.65M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.36k

  • Price/Book (mrq)

    4.69

  • Enterprise Value/Revenue

    9.51k

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 0Y2.BE

View More